Publications by authors named "Ella Willenbacher"

22Publications

Visible and near-infrared hyperspectral imaging techniques allow the reliable quantification of prognostic markers in lymphomas: A pilot study using the Ki67 proliferation index as an example.

Exp Hematol 2020 Sep 20. Epub 2020 Sep 20.

Institute of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria; University Hospital for Orthopedics and Traumatology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2020.09.191DOI Listing
September 2020

Erratum: Willenbacher, E., et al. Curcumin: New Insights into an Ancient Ingredient against Cancer. 2019, , 1808.

Int J Mol Sci 2020 08 10;21(16). Epub 2020 Aug 10.

Department of Internal Medicine V: Hematology and Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21165725DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461099PMC
August 2020

Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia.

Ann Hematol 2019 Nov 18;98(11):2569-2578. Epub 2019 Oct 18.

Internal Medicine V (Hematology & Oncology), Medical University of Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03797-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848044PMC
November 2019

Curcumin: New Insights into an Ancient Ingredient against Cancer.

Int J Mol Sci 2019 Apr 12;20(8). Epub 2019 Apr 12.

Department of Internal Medicine V: Hematology and Oncology, Medical University of Innsbruck, Innsbruck 6020, Austria.

View Article

Download full-text PDF

Source
https://www.mdpi.com/1422-0067/20/8/1808
Publisher Site
http://dx.doi.org/10.3390/ijms20081808DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514995PMC
April 2019

Digital PCR in bone marrow trephine biopsies is highly sensitive for MYD88 detection in lymphomas with plasmacytic/plasmacytoid differentiation.

Br J Haematol 2019 07 14;186(1):189-191. Epub 2019 Feb 14.

Institute of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15792DOI Listing
July 2019

Clinical challenges in a patient with two BRAF V600E-mutated diseases.

Thorax 2019 06 19;74(6):620-622. Epub 2019 Jan 19.

Internal Medicine II, Pneumology, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/thoraxjnl-2018-212481DOI Listing
June 2019

Short overview on the current standard of treatment in newly diagnosed multiple myeloma.

Memo 2018 21;11(1):59-64. Epub 2018 Feb 21.

1Internal Medicine V, Hematology & Oncology, Innsbruck Medical University, Anichstraße 35, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-018-0383-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862912PMC
February 2018

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.

Blood 2017 01 22;129(3):383-385. Epub 2016 Nov 22.

Clinical Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-06-720599DOI Listing
January 2017

Obinutuzumab in multidrug-resistant hairy cell leukemia.

Ann Hematol 2016 Jan 7;95(2):351-2. Epub 2015 Oct 7.

Department of Internal Medicine V, Medical University of Innsbruck, Anichstrasse 35, A-6020, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2520-yDOI Listing
January 2016

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera.

Blood 2015 Oct 10;126(15):1762-9. Epub 2015 Aug 10.

Laboratory for Immunological and Molecular Cancer Research, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-04-637280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608390PMC
October 2015

Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.

Haematologica 2013 Feb 14;98(2):264-8. Epub 2012 Sep 14.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Austiria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2012.072587DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561434PMC
February 2013